Lexicon Pharmaceuticals LXRX Occupancy and Related Charges
Occupancy and Related Charges at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's occupancy and related charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's occupancy and related charges?
- Lexicon Pharmaceuticals (LXRX) reported occupancy and related charges of $500K in Q1 2026.
- How has Lexicon Pharmaceuticals's occupancy and related charges changed year-over-year?
- Lexicon Pharmaceuticals's occupancy and related charges increased by 25.0% year-over-year, from $400K to $500K.
- What is the long-term trend for Lexicon Pharmaceuticals's occupancy and related charges?
- Over 3 years (2022 to 2025), Lexicon Pharmaceuticals's occupancy and related charges has grown at a -3.9% compound annual growth rate (CAGR), from $1.8M to $1.6M.